KRT19 and cancer: Significant association of higher CK19 level (>3.3 ng/ml) with menopausal (p = 0.004), deep myometrial invasion (P < 0.001), lymphovascular space invasion (p = 0.001), ovarian metastasis (P < 0.001), Type II cancer (p < 0.001) and advanced FIGO stage (P < 0.001) were observed.